Peiguo Cao

3.0k total citations
58 papers, 878 citations indexed

About

Peiguo Cao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Peiguo Cao has authored 58 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 26 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Peiguo Cao's work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Peiguo Cao is often cited by papers focused on Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Peiguo Cao collaborates with scholars based in China, United States and France. Peiguo Cao's co-authors include Ke Cao, Jianda Zhou, Ke Cao, Ziying Zhang, Hui Xie, Yuliang Pan, Jianda Zhou, Yuxing Zhu, Peng Chen and Chenghui Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Peiguo Cao

54 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peiguo Cao China 18 581 496 168 130 90 58 878
Chaofeng Ding China 18 833 1.4× 645 1.3× 143 0.9× 116 0.9× 73 0.8× 26 1.1k
Shengni Hua China 16 829 1.4× 587 1.2× 253 1.5× 122 0.9× 65 0.7× 22 1.1k
Zongzhen Xu China 17 475 0.8× 429 0.9× 190 1.1× 235 1.8× 85 0.9× 25 803
Jin He China 16 570 1.0× 356 0.7× 167 1.0× 98 0.8× 85 0.9× 47 907
Zhangqian Chen China 14 700 1.2× 421 0.8× 227 1.4× 115 0.9× 50 0.6× 19 961
Haijian Zhang China 18 579 1.0× 335 0.7× 148 0.9× 138 1.1× 87 1.0× 51 828
Yuchao He China 12 393 0.7× 303 0.6× 112 0.7× 121 0.9× 74 0.8× 25 593
Vijesh Kumar Yadav Taiwan 18 502 0.9× 310 0.6× 173 1.0× 147 1.1× 61 0.7× 41 814
Zhe Yang China 15 407 0.7× 280 0.6× 135 0.8× 101 0.8× 74 0.8× 42 656
Shunjie Xia China 9 534 0.9× 399 0.8× 86 0.5× 98 0.8× 67 0.7× 13 731

Countries citing papers authored by Peiguo Cao

Since Specialization
Citations

This map shows the geographic impact of Peiguo Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiguo Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiguo Cao more than expected).

Fields of papers citing papers by Peiguo Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiguo Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiguo Cao. The network helps show where Peiguo Cao may publish in the future.

Co-authorship network of co-authors of Peiguo Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Peiguo Cao. A scholar is included among the top collaborators of Peiguo Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiguo Cao. Peiguo Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cao, Peiguo, et al.. (2024). Upregulated expression of PTTG1 is associated with progression of pancreatic cancer. Journal of Gastrointestinal Oncology. 15(1). 435–457. 2 indexed citations
3.
Qiu, Meng, Grant Wei, Wendy W.J. de Leng, & Peiguo Cao. (2023). 624P Tolerability and safety of vemurafenib, cetuximab combined with camrelizumab for BRAF V600E-mutated /MSS metastatic colorectal cancer. Annals of Oncology. 34. S446–S446. 3 indexed citations
4.
5.
Wang, Xuan, et al.. (2023). ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis. BMC Medical Genomics. 16(1). 178–178. 2 indexed citations
6.
Qin, Shukui, Jin Li, Haijun Zhong, et al.. (2022). Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial. British Journal of Cancer. 127(12). 2241–2248. 15 indexed citations
7.
8.
Xie, Peng, Qiao Jin, Yifan Li, et al.. (2021). Nanoparticle delivery of a triple-action Pt(iv) prodrug to overcome cisplatin resistance via synergistic effect. Biomaterials Science. 10(1). 153–157. 7 indexed citations
9.
10.
Pan, Yuliang, et al.. (2021). LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer. Translational Oncology. 14(4). 101036–101036. 25 indexed citations
11.
Hu, Hao, Siqi Yan, Long Jin, et al.. (2021). lncRNA MIR22HG-Derived miR-22-5p Enhances the Radiosensitivity of Hepatocellular Carcinoma by Increasing Histone Acetylation Through the Inhibition of HDAC2 Activity. Frontiers in Oncology. 11. 572585–572585. 27 indexed citations
12.
Ding, Juan, et al.. (2020). MEG3 Induces Cervical Carcinoma Cells' Apoptosis Through Endoplasmic Reticulum Stress by miR-7-5p/STC1 Axis. Cancer Biotherapy and Radiopharmaceuticals. 36(6). 501–510. 20 indexed citations
13.
14.
Zeng, Qinghai, Jianye Liu, Peiguo Cao, et al.. (2017). Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy. Clinical Cancer Research. 24(2). 445–459. 56 indexed citations
15.
Peng, Xiaowei, Peiguo Cao, Jingjing Li, et al.. (2015). MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel bothin vitroandin vivo. Cancer Biology & Therapy. 16(2). 261–267. 21 indexed citations
16.
Jin, Qiao, Xiangjun Li, & Peiguo Cao. (2015). EphA2 modulates radiosensitive of hepatocellular carcinoma cells via p38/mitogen‐activated protein kinase‐mediated signal pathways. The Kaohsiung Journal of Medical Sciences. 31(10). 510–517. 7 indexed citations
17.
Liu, Rui, Chengqun Luo, Xiao Zhou, et al.. (2014). Identification of FLOT2 as a novel target for microRNA-34a in melanoma. Journal of Cancer Research and Clinical Oncology. 141(6). 993–1006. 39 indexed citations
18.
Zhang, Xi, et al.. (2012). MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma. SHILAP Revista de lepidopterología. 4 indexed citations
19.
Huang, Chenghui, et al.. (2011). Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 31(4). 488–496. 16 indexed citations
20.
Cao, Ke, Weidong Liu, Hideji Nakamura, et al.. (2009). Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells. Hepatology Research. 39(11). 1108–1117. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaofeng Ding Breakdown of academic impact, for papers by Shengni Hua Breakdown of academic impact, for papers by Zongzhen Xu Breakdown of academic impact, for papers by Jin He Breakdown of academic impact, for papers by Zhangqian Chen Breakdown of academic impact, for papers by Haijian Zhang Breakdown of academic impact, for papers by Yuchao He Breakdown of academic impact, for papers by Vijesh Kumar Yadav Breakdown of academic impact, for papers by Zhe Yang Breakdown of academic impact, for papers by Shunjie Xia
Rankless by CCL
2026